FOLLOWING THE ACQUISITION OF EUSA BY THE RECORDATI GROUP IN MARCH 2022, OUR COMPANY NAME HAS CHANGED FROM EUSA PHARMA (UK) LIMITED TO RECORDATI UK LIMITED FORMING PART OF RECORDATI RARE DISEASES
Of the 7,000 known rare diseases, less than 10% have an available treatment option. Since 2007, through our dedicated business unit Recordati Rare Diseases, we’ve focused on helping the few who suffer from little known conditions.
Our mission is to reduce the impact of rare and devastating diseases by providing urgently needed medicines in key therapeutic areas. This website contains some of the key information regarding medicines previously managed under Eusa Pharma (UK ltd.), including customer service information, product safety contacts and medical information. For additional information on Recordati please follow the link below

